Sōlaria Biō Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 15

Employees

  • Latest Deal Type
  • M&A

Sōlaria Biō General Information

Description

Developer of a plant-sourced synbiotic medical food production platform designed to support bone health and address bone loss through the gut-bone axis. The company's medical food uses beneficial microbes naturally derived from edible plants and is designed to influence the gut-bone axis, enabling women with osteopenia to support bone density, reduce bone loss through a clinically studied, non-prescription approach, and lead a healthier life.

Contact Information

Website
www.solaria.bio
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • 100 Beaver Street
  • Waltham, MA 02453
  • United States
+1 (833)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Parent Company
Vertical(s)
Corporate Office
  • 100 Beaver Street
  • Waltham, MA 02453
  • United States
+1 (833)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sōlaria Biō Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Merger/Acquisition 01-Oct-2026 Completed Generating Revenue
9. Later Stage VC (Series B) 19-Nov-2025 Completed Generating Revenue
8. Later Stage VC 09-Sep-2024 Completed Clinical Trials - General
7. Accelerator/Incubator Completed Clinical Trials - General
6. Accelerator/Incubator Completed Clinical Trials - General
5. Grant 23-Aug-2023 Completed Clinical Trials - General
4. Later Stage VC (Series B) 08-May-2023 Completed Startup
3. Accelerator/Incubator 27-Sep-2022 Completed Startup
2. Early Stage VC (Series A) 11-Sep-2020 $11.3M $11.5M Completed Startup
1. Accelerator/Incubator 26-Jul-2017 $200K $200K Completed Startup
To view Sōlaria Biō’s complete valuation and funding history, request access »

Sōlaria Biō Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B3
Series B2
Series B 12,390,905 $0.000100 $0.93 $0.93 1x $0.93 10.98%
Series A 19,898,765 $0.000100 $0.78 $0.78 1x $0.78 17.63%
To view Sōlaria Biō’s complete cap table history, request access »

Sōlaria Biō Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a plant-sourced synbiotic medical food production platform designed to support bone health and address bone
Drug Discovery
Waltham, MA
15 As of 2026

Cambridge, MA
 

South San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Sōlaria Biō Competitors (4)

One of Sōlaria Biō’s 4 competitors is Concerto Biosciences, a Venture Capital-Backed company based in Cambridge, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Concerto Biosciences Venture Capital-Backed Cambridge, MA
Brightseed Private Equity-Backed South San Francisco, CA
Seed Health Venture Capital-Backed Los Angeles, CA
Pendulum Venture Capital-Backed San Francisco, CA
To view Sōlaria Biō’s complete competitors history, request access »

Sōlaria Biō Patents

Sōlaria Biō Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026072827-A1 Methods and compositions for treating musculoskeletal diseases, treating inflammation, and managing symptoms of menopause in overweight and obese subjects Pending 26-Sep-2024
AU-2022422001-A1 Immunomodulatory compositions comprising microbial entities Pending 21-Dec-2021
CA-3241760-A1 Immunomodulatory compositions comprising microbial entities Pending 21-Dec-2021
EP-4452287-A2 Immunomodulatory compositions comprising microbial entities Pending 21-Dec-2021
US-12016891-B2 Immunomodulatory compositions comprising microbial entities Active 21-Dec-2021 A61K35/747
To view Sōlaria Biō’s complete patent history, request access »

Sōlaria Biō Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sōlaria Biō Former Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
AgeTech Collaborative from AARP Accelerator/Incubator
BOLD Capital Partners Venture Capital Minority
GG 1978 Venture Capital Minority
GISEV Family Office Family Office Minority
Illumina Accelerator Accelerator/Incubator Minority
You’re viewing 5 of 14 investors. Get the full list »

Sōlaria Biō FAQs

  • When was Sōlaria Biō founded?

    Sōlaria Biō was founded in 2017.

  • Where is Sōlaria Biō headquartered?

    Sōlaria Biō is headquartered in Waltham, MA.

  • What is the size of Sōlaria Biō?

    Sōlaria Biō has 15 total employees.

  • What industry is Sōlaria Biō in?

    Sōlaria Biō’s primary industry is Drug Discovery.

  • Is Sōlaria Biō a private or public company?

    Sōlaria Biō is a Private company.

  • What is Sōlaria Biō’s current revenue?

    The current revenue for Sōlaria Biō is .

  • How much funding has Sōlaria Biō raised over time?

    Sōlaria Biō has raised $37.4M.

  • Who are Sōlaria Biō’s investors?

    AgeTech Collaborative from AARP, BOLD Capital Partners, GG 1978, GISEV Family Office, and Illumina Accelerator are 5 of 14 investors who have invested in Sōlaria Biō.

  • Who are Sōlaria Biō’s competitors?

    Concerto Biosciences, Brightseed, Seed Health, and Pendulum are competitors of Sōlaria Biō.

  • When was Sōlaria Biō acquired?

    Sōlaria Biō was acquired on 01-Oct-2026.

  • Who acquired Sōlaria Biō?

    Sōlaria Biō was acquired by Viome Life Sciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process